St Teresa Medical is a pioneering brand that was established in 2010. They specialize in commercializing an innovative technology that originated from Virginia Commonwealth University, in collaboration with the Henry Jackson Foundation for the Advancement of Military Medicine. Originally developed for treating battlefield trauma, St Teresa Medical has acquired a license for this groundbreaking invention and has further enhanced its intellectual property.

Their aim is to revolutionize the hemostatic and therapeutic markets with the use of soft matter nanotechnology fibers, ultimately improving patient outcomes and saving lives. St Teresa Medical's platform technology is specifically designed to address life-threatening bleeding and fluid leaks during surgery, as well as facilitate wound healing. With a comprehensive history of accomplishments, including worldwide technology licensing, numerous patent applications, pre-clinical trials on various species, successful human clinical trials in multiple countries, and obtaining ISO 13485 certification and GMP compliance, St Teresa Medical is making significant strides in the medical field.

While their dissolvable hemostatic dressing is not yet cleared for use in the US or EU, St Teresa Medical anticipates FDA Phase III IND approval in the near future. For those ready to take control of bleeding, St Teresa Medical is ready to assist. Contact them today to learn more about their groundbreaking products and services